blank spaceblank spaceNational Research Council Canada / Conseil national de recherches Canadablank spaceGovernment of Canada
Skip all menus (access key: 2)Skip first menu (access key: 1)Menu (access key: M) Français Contact us Help Search Canada Site
BRI blank space News Health Sector Bioprocess Sector Environment Sector NRC Site
Services Business Laboratory Space Publications Careers
Banner - Business
blank space Business Patents Licensing Opportunities Contract Templates Contact Us blank space

PrinterPrinter friendly

Active Issued Patents and Patents Undergoing Prosecution

The Biotechnology Research Institute has an intellectual property portfolio for licensing that related to its three sectors of activities in Health, Bioprocess and Environment. The list bellow contains the files that have issued patents.


NRC File    
number    

Health

11740 Characterization of small molecules by MS/MS/MS technique of QTOF Global
11615 Polypeptide Ligands Containing Linkers Or Polypeptide Ligands containing linkers Biomolecular Tweezers: Bivalent Polypeptide Ligands Containing Flexible Linkers Sensitive To Chemical Modification, Binding Or Bio-Recognition
11570 Tetracycline Derivatives-Based Neuroprotective Agent Platform Against Excitotoxicity and Caplain Inhibitor
11444 Cournermycine/Novobyocin regulated gene expression
11391 Staphylococal Nuclease Fusion Proteins for the Production of Recombinant Peptides
11389 Preparation, Characterization and Quantitation of Active Fraction that Promote Cell growth and Recombinant-Protein Expression
11388 Peptide Inhibitors of Thrombin as Potent Anticoagulants
11374 Drug evolution / Drug Design at Hotspot
11342 Quantitative Ranking of Transient Ligand Binding to Target Biomolecules
11323 Antiglycation Agents for Preventing AGE- Diabetes-, and Smoking-Related Complications
11225 A system for inducible expression in eukaryotic cells
11131 Compositions, methods and kits for identifying protein-protein interaction disrupting agents
10664 Cloning of Galanin Receptor GALR
10472 Novel G protein-coupled receptor
10291 Bivalent thrombin inhibitors
10099 Thrombin inhibitors based on the amino acid sequence of hirudin


Bioprocess

11648 Development of a reverse Cumate transactivator (rcTA): application for protein production in CHO cells. Also called: Expression, components thereof and method of use
11622 High Performance liquid chormatography-fluorescent detection of recombinant viruses by labeling of the viral genome
11575-2 Synthetic Genes Encoding Proteins of Reproductive and Respiratory Syndrome Virus and Uses thereof
11565-1 New serum free 293 cell line
11404 Methylotrophic bacterium for the production of recombinant proteins and other products
11389 Preparation, Characterization and Quantitation of Active Fraction that Promote Cell growth and Recombinant-Protein Expression
11357 Porcine reproductive and respiratory syndrome virus (prrsv) DNA vaccines
11327 Methylotrophic bacterium for the production of recombinant proteins and other products
11320 Sterilizable probe for extraction of volatile compounds in liquids and their quantitative determination
11266 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
11225 A system for inducible expression in eukaryotic cells
10894 Serum free production of recombinant proteins and adenoviral vectors / Cluster
10890-1 Adenovirus mutants with deleted protease gene
10890-2 Complementary cell line for the growth of adenovirus mutants with a deleted protease gene
10890-3 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
10834 CRE-inducible expression system
10689 Streptomyces microorganism useful for the preparation of (R)-baclofen from the racemic mixture
10624 Adenovirus E1-complementing cell lines
10269 Sugar/sugar alcohol esters
10230 Process for the preparation of poly-beta-hydroxybutyric acid polymers


Environment

11654 A Thermostable S-Esterase Capable of Racemic Resolution of 2-Benzyloxy-Propionic Acid Ethyl Esters
11637 Impedance Sensing of DNA Binding Drugs using Gold Substrates Modified with Gold Nanoparticles
11634 Application of multi-wavelength fluorometry for on line bioprocess monitoring
11569-1 Method and Apparatus for the Detection of Microorganims and cytotoxicity
11509 Process for producing gold nanoparticles
11497 Process for treating an effluent polluted by MTBE or TAME using the Mycobacterium austroafricanum I-2562 strain fixed on a mineral support comprising perlite
11458 DNA Microarray for Fingerprinting and characterization of Microorganisms and Microbial CommunitiesFplasmid
11434 Virulence and antibiotic resistance array and uses thereof
11425 Degradation of Cyclic Nitramines
11390 Bioelectrolytical methanogenic/methanotrophic coupling for bioremediation of ground water (emamoc)
11313 A gene encoding cyclododecanone monooxygenase
11293 Array and uses thereof
11225 A system for inducible expression in eukaryotic cells
11167 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli
11136 Bioremediation of nitrate contaminated groundwater
10707 Immobilization of bacterial cells or sludge using chitosan crosslinked with lignosulphonate
10633 Bioreactor for biological treatment of contaminated water
10344 Anaerobic and aerobic integrated system for biotreatment of toxic wastes (canoxis)
10304 Redox dye and method of preparation thereof using 2-hydroxypropyl-.beta.-cyclodextrin and 1,1'-dimethylferrocene
10091 Treatment of organic compounds to reduce chlorine level
blank spaceFooter Line
Date Modified: 2006-09-29
Top of page